Top compounds associated with response to TCL1B


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.07 0.01
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.02
mRNA SKI-II CTRPv2 pan-cancer AAC 0.086 0.02
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.077 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.02
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.072 0.02
mRNA narciclasine CTRPv2 pan-cancer AAC -0.077 0.02
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.074 0.02
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.084 0.02
Download CSV